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ABSTRACT 
 
Messenger-RNA (mRNA) therapy, in which mRNA is introduced to cells or tissues to cause a 
transient expression of specific genes, has applications ranging from tissue engineering to neural 
regeneration. This transient nature of mRNA, however, limits the duration of gene upregulation, 
and potentially reduces the efficacy of mRNA therapy. 
 
In this paper, various mRNA constructs were studied to identify stable designs which could be 
used for long-lasting mRNA therapies. Specifically, the GFP gene was prepared with four 
different hemoglobin untranslated regions (UTR’s), which are known for their stabilization 
effects on mRNA. Each mRNA template was created through the digestion and ligation of a 
cDNA template, reversed transcribed from total RNA, and transfected into fibroblasts. The 
resulting fluorescence was measured as a surrogate for translation efficiency and duration. It was 
determined that the human beta-globin B UTR resulted in a fluorescence level that was tenfolds 
brighter than human alpha-globin 1 (HBA1), which was the least effective stabilizing 
untranslated region. This highlights the importance of UTR selection for future mRNA therapies. 
 
Thesis Supervisor: Mehmet F. Yanik 
Title: Robert J. Shillman Career Development Associate Professor of Electrical Engineering  
          Associate Member, Broad Institute 
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1.  Introduction  
 
 Neurons from the peripheral nervous system (PNS) can exhibit partial functional 
regeneration after injury, while injured neurons from the central nervous system (CNS) do not 
recover. This difference in regeneration capacity is due to two main factors: injured CNS 
neurons lack the ability to activate the required intracellular factors for enhancing neurite growth, 
and the extracellular environment in the injured CNS releases inhibitory factors which prevent 
neurite regrowth. An approach to solve the first issue is to artificially enhance the expression of 
proteins known to encourage neurite outgrowth by transfecting neurons with the mRNA 
encoding these proteins. Furthermore, this strategy holds additional promise: the tips of 
developing neurons contain ribosomes that can locally translate mRNA to achieve high levels of 
growth-promoting proteins at the site of injury. mRNA is also safer to use relative to DNA 
because it does not interfere with the genome and therefore mitigates the risk of cancer 
associated with this therapy. However, the main drawback of mRNA is its instability and its 
shorter half-life relative to that of DNA, resulting in only a transient expression of regeneration 
genes.  
The main goal of this project is to focus on the 5’ and 3’ untranslated regions (UTR) of the 
mRNA in order to stabilize the mRNA coding strand itself. A range of different stabilizing 5’ 
and 3’ untranslated regions will be digested with their corresponding restriction enzymes, and 
subsequently ligated to destabilized GFP. These newly-formed genes will be screened for 
marked enhancement of green fluorescent proteins (GFP) expression stability in fibroblasts. By 
measuring the time-course of fluorescence in fibroblasts, we can identify the untranslated regions 
which provide the highest stability of protein expression. By maximizing the half-life of the 
mRNA, the required therapeutic dosage, and associated costs and risks, will be minimized for 
this therapy. 
2. Background  
 
2.1 Untranslated Regions Selection 
Most mRNAs have half-lives that last from several minutes to several hours, as they are 
destroyed by intracellular exo- and endonucleases. However, mRNAs from globins have been 
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known to have half-lives that last from 16 hours to 48 hours, which is useful for mRNA therapy. 
Specifically, the 3’ UTR is known to play a large role in mRNA stabilization, as a variant in the 
α- globin gene 3’ UTR is known to cause nondeletional α- thalassemia1. The mutation leads to 
the ribosome reading through the stop codon, causing disruption to the sequences or structures 
within the 3’UTR of the α- globin mRNA, and mRNA destabilization 
 In addition, one study of α- and β- globin gene stabilization shows that they have 
different mechanisms of stabilization due to the level of expression when exposed to the α – 
variant. α- globin was shown to have less than 2 percent expression which is in contrast to the 40 
percent expression of β- globin. Also, the α- globin in mRNA is destabilized when ribosomes 
read 4 codons into the 3’ UTR, whereas β- globin destabilization occurs only if the ribosome 
reads further into the 3’UTR.2 These two observations indicate that the α- and β- globins have 
different mechanisms of 3’ UTR stability, and therefore, one globin might have a larger role in 
stability or have a longer half-life compared to the other globin.  
The poly-A tail, found at the end of the mRNA, is another crucial factor in mRNA 
stability. This tail prevents the mRNA from degrading in the cytoplasm, promotes efficient 
translation of the mRNA, as well as keeping the mRNA stable during the exportation from the 
nucleus to cytoplasm. Once transcribed, the poly-A tail gradually shortens due to exonuclease 
activity. Once the tail has degraded, the mRNA is rapidly destroyed. 
To try and extend the life of mRNA, a poly(thio-adenosine) tail was also investigated, 
due to the non-hydrolysable sulfur bond that might increase stability. A poly-U polymerase was 
found to efficiently add 1-thio-adensone to the tail for this purpose. 
In summary, four different globins 3’ UTR were used for this experiment, as well as a 
variant poly-A tail: β- globin (HBB), α-1- globin (HBA1), α- 2 – globin (HBA2), a sextuplet 
repeat of α- 2 – globin (polyHBA2), and HBB with  a poly A tail, capped by a short run of 1-
thio-adensonies (thioHBB). 3 
                                                 
       
1
 JE Russell and SA Liebhaber, "The stability of human beta-globin mRNA is dependent on structural  
           determinants positioned within its 3' untranslated region," Blood 87 (1996): 5314-5323. 
2
 Ibid. 5314-5323. 
3
 Ibid. 5314-5323. 
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2.2 Use of Pseudouridine 
Pseudouridines are used in the mRNA template, rather than uridines, as this results in more 
translation and a lower innate-immune response4.  This enhancement is due to the fact that 
uridine activates RNA-dependent protein kinase (PKR), which is known to phosphorylate 
translation factor 2-alpha, and thus inhibit translation. Pseudouridines are known to evade PKR, 
and thus there is more translation, and less immune response. Although both uridine and 
pseudouridine both have some suppressive effect on translation, there was a noticeable larger 
suppression of protein synthesis in unmodified or uridine-containing mRNA compared to 
pseudouridine containing mRNA. 
 
 
Figure 1: mRNA encoding Renilla luciferase and Firefly luciferase were transfected with 
and without pseudouridine modification and then mixed. The above shows that with both 
modified mRNA, there was more luciferase activity than in transfection with unmodified 
mRNA.5 
 
The above figure from Kariko’s study shows that when both mRNA were modified with 
pseudouridine, there was relatively more activity than when both mRNA were unmodified with 
uridine. Additional experiments also showed that the beneficial effects of pseudouridine is 
independent of cap and poly(A) tail, which are known to help stabilize mRNA further. 
                                                 
4
 Katalin Kariko and Bart Anderson, "Incorporation of pseudouridine into mRNA enhances translation by  
   diminishing PKR activation," Nucleic Acids Research (2010): 1-9. 
5
 Ibid. 3.  
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 In addition, mRNA is known to induce an immune response from the body, thus making 
it less effective for gene replacement therapy. However, by using pseudouridine, most of the toll-
like receptors that activate cells of the innate immune system are inactivated. This inactivation is 
due to the relation between uridine and RIG-I, in which type I interferon secretion occurs when 
mRNA contains 5’ triphosphate. However, when using modified mRNA, this replacement 
inactivates the secretion of interferon and therefore diminished its immunogenicity in vivo.6 
3. Preparation of mRNA Template and mRNA Transfection into Fibroblast Cells 
 
3.1 Creating the DNA Template 
 From a total-cell lysate from rat hippocampal neurons, the total RNA was extracted and 
isolated from the DNA using the Qiagen RNEasy Mini Kit. The extracted total RNA was then 
reverse transcribed in order to obtain the cDNA that will serve as the template for the mRNA. 
Table 1. Reverse Transcription Protocol 
Reverse Transcription 
Final 
Concentration 
Per 20uL 
Reaction Temperatures 
mRNA Template  10 65C-45min 
5uM ivT Reverse Primers 0.25uM 1 90C-5min 
10mM dNTP Mix 200uM 0.4 4C-forever 
MonsterScript Reverse Transcriptase 1:20 1   
5x MonsterScript Buffer 1x 4   
H2O  3.6   
    20 uL Total 
 
 5’ and 3’ UTR’s were isolated from the cDNA mixture by choosing the complimentary 
primers based on HBB, HBA1, HBA2 and pHBA2 5’ and 3’ UTR genetic sequences. Also, the 
coding sequence (CDS) for destabilized Green-Fluorescent Protein (dsGFP) and Green-
Fluorescent Protein (GFP) were obtained from Clontech. Using the following PCR protocol, the 
UTR’s and CDS were amplified twice—first time to isolate the UTR and CDS from other DNA 
sequence and second time to increase the concentration of UTR and CDS. 
  
                                                 
6
 Katalin Kariko, “Incroporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With  
   Increased Translational Capacity and Biological Stability,” The American Society of Gene Therapy 16  
   (2008): 1833-1840 
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Table 2. PCR Protocol for HBB 5-UTR 
HBB 5-UTR Kz 
Final 
Concentration 
Per 25uL 
Reaction Temperatures   
5x HF Buffer 1X 5 95C - 5min   
10mM dNTP Mix 200uM 0.75 98C - 15sec   
5uM HBB 5-UTR Forward Primer .5uM 2.5 68C - 30sec 
x15 
cycles 
5uM HBB 5-UTR Reverse Primer 2 .5uM 2.5 68C - 2min   
RT Reaction  1 4C - forever   
KAPA HiFi Hot-Start DNA Polymerase 0.5U 0.5    
H2O H2O 12.75     
  25 uL Total  
 
Gel electrophoresis was used to isolate the UTR and CDS from other extraneous DNA, 
RNA and protein. The gel was made up of 1.5% agarose, along with 3mL of TAE buffer and 
4µL of Ethyl Bromide. TriDye 2-Log DNA Ladder was used as the standardized ladder to 
determine the relative length of UTR. Afterwards, the correct band was extracted using the 
QiaQuick Gel Extraction Kit. This process was repeated to obtain the following UTR’s: 5’ HBB 
UTR, 5’ HBA1 UTR, 5’ HBA2 UTR, 3’ HBB UTR, 3’ HBA1 UTR, 3’ HBA2 UTR, 3’ pHBA2 
UTR, GFP, and dsGFP.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: In order to determine that the gene we obtained was dsGFP, we knew that 
dsGFP had a length of 0.925 kb whereas GFP had a length of 0.755 kb. This gel indicates 
that we have obtained the right gene for this study. 
 
0.5kb 
1.0kb 
3.0kb 
dsGFP GFP 
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Afterwards, the 5’ UTR and 3’ UTR are digested with their restriction enzymes--Nhe I and 
Age I, respectively. GFP and dsGFP were digested with both Nhe I and Age I as well with the 
following digestion protocol:  
Table 3. Restriction Enzyme Digestion Protocol 
Digestion 
Final 
Concentration 
per 50uL 
Reaction Temperatures 
10X NEBuffer 1 1X 5 37C - 1hr 
100X BSA 1X 0.5 65C - 20 min 
CDS or HBB UTR PCR Product 0.25-1.5ug 30   
AgeI (restriction enzyme) 2.5U 0.5   
KpnI-HF (restriction enzyme) 2.5U 0.5   
H2O  13.5   
    50 uL Total 
 
The digested products are purified using the QiaQuick Gel Extraction Kit before being 
ligated together using the following ligation protocol:  
Table 4. Ligation Protocol 
Ligation 
Final 
Concentration 
per 50uL 
Reaction Temperatures 
10X E.coli DNA Ligase Buffer 1X 5 16C - 18hr 
Digested CDS Kz PCR Product 10-50nM 15 65C - 20min 
Digested HBB 5-UTR kz PCR Product 50nM 5 
1.5% Gel - 
150ml 
Digested 3-UTR PCR Product 25nM 5 Elute in 30uL 
E.coli DNA Ligase 5U 2.5   
H2O  17.5   
    50 uL Total 
 
The following DNA template was created after the ligation step, purified, and amplified 
using the PCR protocol:  
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Figure 3: The DNA template consists of a T7 promoter, allowing for transcription to take 
place. The 5’UTR and 3’UTR are ligated onto the coding sequence with different 
restriction site – Nhe I and Age I, respectively. In order to ensure that the UTRs are 
effective, we used the coding sequence of dsGFP so that the only way to stabilize dsGFP 
would be through the UTRs and not through its own stabilizing UTRs. 
 
As a result, the following cDNA templates were created:  
5’ HBB UTR – dsGFP – 3’ HBB UTR 
5’ HBA1 UTR – dsGFP – 3’ HBA1 UTR 
5’ HBA2 UTR – dsGFP – 3’ HBA2 UTR 
5’ HBA2 UTR – dsGFP – 3’ pHBA2 UTR 
After the DNA templates were created, the templates were inserted into a bacterial plasmid, 
which are then transfected into e.coli bacteria. Colonies were grown overnight, and only the 
e.coli colonies that took up the plasmid successfully will be able to grow on the kanamycin-
treated LB agar plate. The colonies are then grown in 100ml flasks and plasmids are removed 
using a Qiagen Maxi-kit. The plasmids are then quantitated and diluted to 1ug/6uL and run on a 
gel in order to ensure the correct DNA template was obtained by looking at its relative length 
along the ladder. Then the sample is sent for sequencing in order to further assure that the right 
sequence of cDNA template was obtained. 
 
3.2 Creating the mRNA Template 
The DNA template from the previous step will be used to create the mRNA template. The 
first step is to transcribe the mRNA from the DNA template using this protocol:  
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Table 5. In Vitro Transcription Protocol 
in vitro Transcription per 20uL Reaction per 50uL Reaction Settings: 
Rnase-free water 0.8 2 
37C for 
2hs 
mScript 10x Transcription Buffer 2 5   
NTP Solution* 7.2 18   
100mM DTT 2 5   
mScript T7 Enzyme Mix 2 5   
T7 Template 6 15   
Total 20 50   
*The NTP solution used here consists of adenine, cytosine, thymine, and pseudo-uridine rather 
than uridine due to pseudouridine contribution to mRNA stability, higher protein expression, and 
decreased immunogenicity.  
 
 1uL of DNA digestion enzyme per 20 uL reaction is added and held at 37C for 15 
minutes. This is to ensure that all the DNA templates are digested within the solution. In order to 
purify the mRNA, an RNeasy RNA extraction kit is used to remove DNA template and proteins 
that may remain within the solution. The RNA is then quantitated in order to determine the 
amount of mRNA gained from the IVT transcription. A sample of the uncap/untail mRNA is 
stored in order to compare later with the cap/tail mRNA. Afterwards the 5’ cap and 3’ tail is 
added to the mRNA in order to stabilize the mRNA as well as prevent the mRNA from 
degrading.  The 5’ cap is added using the following protocol:  
mRNA is denatured at 65C for 10 minutes prior to capping  
Table 6. 5’ Capping mRNA Protocol 
5' Capping per 100uL Reaction Settings: 
10x ScriptCap Capping buffer 10 37 degrees 1hr 
20mM GTP 5 65C for 10min 
20mM SAM 1   
ScriptGuard 2.5   
mScript Capping Enzyme 4   
mScript 2'-O-Methyltransferase 4   
Heat Denatured RNA 73.5   
Total 100   
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Solution of mRNA is denatured at 65C for 10 prior to tailing 
Table 7. PolyA Tailing mRNA Protocol 
PolyA Tailing 
per 123.5 uL 
Reaction Settings: 
5' Capping Product 100 37 degrees 
ScriptGuard Rnase Inhibitor 0.5 
40 minutes 
(EXACTLY) 
mScript 10X Tailiong Buffer 12 hold at 4C (for 0s!) 
20mM ATP 6  
mScript Poly(A) Polymerase 5  
Total 123.5  
 
It is important to determine the tailing time for each mRNA in order to ensure that each mRNA 
tail is the same length compared to the uncap/untail mRNA. By keeping the mRNA tail the same 
length, this will ensure that the stability of the mRNA is entirely due to the 3’ UTR, rather than 
the tail length of the mRNA. The completed mRNA is then purified using the RNeasy kit and 
quantitated to determine the amount of mRNA gained from the procedure. The mRNA is then 
diluted to the smallest concentration of the different type of mRNAs obtained and superase 
inhibitor is added to each mRNA in order to prevent degradation. The following mRNA template 
is created as a result:  
 
Figure 4. RNA Template is similar to DNA template in terms of 5’UTR, Coding 
Sequence, and 3’UTR. The only difference is the addition 5’ CAP to prevent degradation 
when the mRNA travels into the cytoplasm of the cell. Also, the Poly A Tail adds 
stability to the mRNA. 
 
Five different mRNAs were created using the above protocol:  
5’ CAP – 5’ HBB UTR -dsGFP- 3’ HBB UTR – Poly A Tail 
5’ CAP – 5’ HBA1 UTR -dsGFP- 3’ HBA1 UTR – Poly A Tail 
5’ CAP – 5’ HBA2 UTR -dsGFP- 3’ HBA2 UTR – Poly A Tail 
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5’ CAP – 5’ HBA2 UTR -dsGFP- 3’ pHBA2 UTR – Poly A Tail 
5’ CAP – 5’ HBB UTR -dsGFP- 3’ HBB UTR – Poly A Tail + Poly thio-A Tail 
The last mRNA (thioHBB) was created in order to determine if the sulfur bonds in the Poly thio-
A Tail contribute more to the stability of the mRNA. An RNA gel is created in order to see if the 
cap/tail length is the same across all RNA. Also, the RNA gel also shows whether the 
quantitation is correct so that equal amount of mRNA can be used to transfect cells each time. 
 
Figure 5. This RNA gels compares the uncap/untail mRNA with the cap/tail mRNA. The 
gap between each uncap/untail mRNA and cap/tail mRNA is about the same, showing 
that the tail length for each mRNA is approximately the same length and thus tail will not 
influence the stability within this experiment. Also, the cap/tail mRNA are about equal 
brightness, which shows that the mRNA are diluted to the same concentration so that 
concentration will not play a role in fluorescence level as well. 
 
3.3 mRNA Transfection into Cells 
Once fibroblasts were plated into 6-well plates and incubated overnight, mRNA is prepared by 
mixing with OptiMEM (cell media) and RNAiMax (binds the RNA to lipid, which cells will 
intake through endocytosis). Therefore, once the solution is prepared according to Table 9: 
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Table 9. mRNA Transfection Solution and Protocol 
OptiMEM 100 uL/ug RNA 
RNA 1 Ug 
RNAiMax 5 uL/ug RNA 
NeuroMAG 3.5 uL/ug RNA 
IMMEDIATELY pipette RNAiMax up and down when added to 
optimem 
Set a timer for 15 minutes since added to the first sample 
 
The solution is pipetted into each well. Afterwards, cells are monitored every 6-8 hours for the 
first 48 hours and then cells are measured every 24 hours afterwards.  The expression of dsGFP 
was measured using epifluorescence. At each timepoint, five images are randomly taken per 
well. After 152 hours, each cell’s fluorescent intensity is measured and averaged in order to 
determine the average amount of fluorescent per hour. The highest level of fluorescence will 
indicate the highest level of stability provided by the 3’UTR for the mRNA.  
4. Results and Data Analysis 
By monitoring the fibroblasts over 152 hours, cells transfected with mRNA with various 
3’UTR’s showed significantly different fluorescence levels. Also, all RNA reached a peak in 
fluorescent level at about 40 hours before decreasing, once the mRNA had all been translated 
and expressed in protein:  
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Figure 6. These images of fibroblasts expressing GFP with HBB UTR illustrate the 
brightness time lapse over 56 hours. Each image is at a different exposure due to the 
exponential increase in fluorescence. HBB at time exposure of 250ms after 10 hours (top 
right), HBB at time exposure of 60ms after 18 hours (top middle), HBB at time exposure 
of 60ms after 26 hours (top right), HBB at time exposure of 40ms after 32 hours (bottom 
left), HBB at time exposure of 50ms after 48 hours (bottom middle), HBB at time 
exposure of 50ms after 56 hours (bottom right). 
 
HBB has the highest level of fluorescent from the brightness of the cell nuclei as well as the 
shortened camera exposure. ThioHBB resulted in less translation, which suggests that the poly U 
tail did not add more stability and might actually decrease the stability of mRNA. HBA2 and 
pHBA2 has the same level of stability, showing that the HBA2 repeats did not enhance the 
mRNA stability. Finally HBA1 had the lowest level of stability of all the 5 mRNAs. 
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Figure 7. This graph measures the relative fluorescence of each mRNA with time in 
hours.  HBB has the highest fluorescence level and HBA1 has the lowest fluorescence 
level.  
 
Overall, the trend and images show that HBB results in the most fluorescence and therefore is 
likely the most effective in terms of mRNA stability, whereas HBA1 is the least fluorescent and 
therefore the least effective in terms of mRNA stability.  
The curves can be described by considering the half-life of mRNA and half-life of the protein. 
The transfection process can be modeled as seen with figure 8 and the following equations can 
be used to describe this process: 
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Figure 8. This representation shows the relationship of the concentration of the bath 
(media), concentration of mRNA, and the concentration of protein and their relationship 
to one another.   
 
mdBu
m CkCk
dt
dC
2−=        (1) 
pdmp
p CkCk
dt
dC
1−=       (2) 
 Where Cm is the concentration of mRNA, Cp is the concentration of protein, CB is the 
concentration of bath, ku is the rate of uptake, kp is the rate of mRNA to protein, kd1 is the rate of 
protein degradation, and kd2 is the rate of mRNA degradation.  
However, equation (1) can be simplified since CB is only crucial within the first four hours of the 
experiment, and since the experiment was done over 152 hours, CB  becomes negligible and 
therefore equation (1) is now:  
md
m Ck
dt
dC
2=            (3) 
 
 
CmRNA 
 
CProtein 
KUptake 
KDegrade2 
KDegrade1 Kprotein 
 
Cbath 
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By solving for equation (2) and (3) with the following boundary conditions:  
Cm = C0m at t = 0,  
Cp = 0 at t = 0, 
Then the solution is:  
tk
m
detC 2)( −=       (4) 
( )tktk
dd
p
p
dd ee
kk
k
tC 12
21
)( −− −⋅





−
=     (5) 
When this model was fitted with the data for HBB and pHBA2, the resulting plot appeared: 
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Figure 9. HBB and pHBA2 data fitted with the curves as predicted from the suggested 
model above. 
 
The model does not fully predict the observed protein expression dynamics. In particular, it is 
unable to recapitulate the sharp peaks in expression suggested by the data. There are some 
limitations to the model due to the assumptions made in order to solve the differential equations. 
One assumption made was that the mRNA intake was instantaneous and therefore mRNA 
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concentration was modeled as an exponential decay curve. In reality, the mRNA is added to the 
cells at time t=0 hours, and requires several hours to be uptaken to the cell, several more hours to 
be released from endosomes, and then several more hours for protein translation to be completed. 
The first two factors would cause a non-instantaneous upswing in mRNA concentration. The last 
factor would add a simple delay to the protein expression curve. Taking all three of these factors 
into account would allow the model to more accurately recapitulate the peaks seen in the data. 
The protein decay segment in the latter part of the experiment is fits the simple model accurately. 
5.  Further Experiments 
Currently, growth factors for neurons are being created through a similar method in the 
procedure section of this study. GAP, CAP, CSTAT3, and ATF3 coding sequences will be 
ligated with 5’ HBB UTR and 3’ HBB UTR due to its high stability effect on mRNA. These 
genes will then be transfected into neurons and cell growth will be measured by taking images 
and measuring the length of neurites.  
6. Discussion 
HBB has the highest fluorescent level of all the mRNA, followed by thioHBB. HBA2 and 
pHBA2 had the next highest fluorescent level, and finally HBA1 had the lowest fluorescent 
level. This result indicates that HBB a very effective stabilizing untranslated region, resulting in 
ten times the fluorescent intensity compared to the HBA1 fluorescent level. Based on the images 
of the experiment, HBB required a significantly shorter exposure time compared to other mRNA 
and was more evenly expressed in many cells compared to other mRNA-transfected cells. 
However, there are limitations to this result, since the experiment was only completed once, the 
standard deviation was quite large. Also, the cells were manually clicked upon for measurement 
and therefore there was scope for human error as well. Finally, the number of cells within each 
well was assumed to be roughly equal. Nevertheless, since HBB was so fluorescent compared to 
other mRNA, these errors are negligible in terms of relative brightness compared to one another.  
Improvements to this experimental design could be done in terms of the data analysis and 
measurements to be taken. Rather than manually clicking on each cell, by writing a program that 
automatically identifies a cell will make the data collection more accurate. Also, by taking the 
number of fluorescent nuclei over the total number of nuclei within the well will give a more 
accurate comparison across all 6 wells. Finally, another suggestion is to plate the same number 
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of cells per well and to take the total fluorescent signal per well. However, even with these 
experimental limitations, HBB resulted in significantly higher protein expression. This result 
highlights the importance of UTR selection for mRNA stability. In the next step, these mRNA-
encoding growth factors will be transfected into neurons to encourage neurite outgrowth. 
Therefore, by maximizing the half-life of mRNA, not only will this knowledge help with the 
next portion of the experiment, but it will help lower mRNA therapeutic dosage as well as 
mRNA risk associated with mRNA therapy. 
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